OTC Pharma Asia is the ONLY regional OTC and health supplement marketing conference in Asia, featuring success stories from Heads of OTC, health supplements and consumer health marketers from across the region.
The only regional OTC Pharma Conference focusing marketing and branding strategies of consumer health products in Asia, featuring key industry players including GSK, BI,J&J and many more.
2nd Med Device Brochure | 16-19 Nov 2015 SingaporeHelen P
Med Device Asia is the only senior industry gathering in Asia for medical device companies, manufacturers, investors and other stakeholders to promote innovation, accelerate approvals and explore the fastest way to market expansion.
IBC’s OTC Pharma Asia conference is returning 2-5 March 2015 at Grand Copthorne Waterfront Hotel, Singapore to prepare you for future growth in the OTC and Consumer Health market in Asia. You will witness how the OTC landscape varies by country as well as the latest product trends, consumer insights and innovative offerings in OTC – a crucial element to achieve global success.
http://www.otcpharmaasia.com
4th Annual OTC Pharma Asia 2014, SingaporeRita Barry
OTC sales in Asia-Pac region (excl. Japan) account for 21% of global OTC sales as of Sept 2012, according to IMS analysis. In fact, for the 3rd consecutive year, Asia-Pac sales have significantly outpaced the global OTC market growth. At the center of the growth, it becomes a priority for Asian consumer health companies to continue reinventing their business as the market becomes more competitive than ever.
The annual OTC conference is the first and only regional platform in Asia to access the latest market trends, regulatory updates, marketing strategies as well as strategic advice by industry experts to achieve sustainable growth and maximize ROI in the evolving consumer health market.
Key Discussion Themes:
Market Entry & Expansion Strategies in Asia
Updates on ASEAN Health Supplement Regulations
Driving OTC Business Growth with Prescription Sales
Promoting OTX/Pharmacist-Only-Medicine
Segment Marketing: Targeting Women, Elderly & Children’s Health
Consumer Trends & Growth Strategies in China & Indonesia’s Consumer Health Market
Launching a New OTC Brand Successfully
OTC Consumer Segmentation, Innovation & Branding Tools
Shopper Marketing for Pharmaceutical Industry
For more information, visit: www.otcpharmaasia.com
The document provides recommendations for MuscleTech to increase its market share in China, including conducting market research, launching in China by the end of 2016, differentiating its brand positioning, building its brand image through ambassadors and campaigns, opening 10 retail stores by 2018, increasing R&D spending to develop products for Chinese consumers, and market testing in Beijing and Shanghai. With these recommendations, MuscleTech expects to achieve 10% market share in Beijing and Shanghai by the end of 2017.
The document discusses the Indian health and wellness market. It notes that the market is worth INR 490 billion and covers segments like beauty and cosmetics, fitness and slimming, nutrition, alternative therapy, and rejuvenation. Younger consumers with higher incomes are driving growth in discretionary spending on wellness. Increased lifestyle diseases and health awareness are also fueling demand for wellness products and services. Medical tourism is seen as a fast-growing segment for India due to lower costs and growing awareness of alternative therapies like Ayurveda. The market is attracting both domestic and international players looking to capitalize on the growth opportunities.
The document discusses the wellness and spa industry in India. It notes that the industry is currently in a growth stage and gaining popularity. Spas have been working to expand their businesses and connect with consumers. There is significant scope for the industry to flourish as lifestyle demands are shifting towards wellness. However, the industry faces limitations like spas unwilling to share customer data and lack of trained professionals. Trends seen include medical tourism and tie-ins between spas and the medical industry. The conclusion is that India presents many opportunities in the growing wellness tourism sector.
This document provides an overview of health and wellness trends in India. It finds that Indians are increasingly health-conscious and spending more on fitness, nutrition, and natural health products. Alternative beverages to carbonated drinks, like reduced-fat flavored milks, are growing in popularity. Fortified foods and beverages are also growing, though consumer awareness remains low. The market for "better-for-you" foods emphasizing reduced fat, sugar, cholesterol, and calories is expanding, especially in urban areas. There were over 1,000 new product launches in India in 2009 focused on these health and wellness attributes. The nutritionals market, including vitamins, herbal products, and slimming aids is also experiencing strong
The only regional OTC Pharma Conference focusing marketing and branding strategies of consumer health products in Asia, featuring key industry players including GSK, BI,J&J and many more.
2nd Med Device Brochure | 16-19 Nov 2015 SingaporeHelen P
Med Device Asia is the only senior industry gathering in Asia for medical device companies, manufacturers, investors and other stakeholders to promote innovation, accelerate approvals and explore the fastest way to market expansion.
IBC’s OTC Pharma Asia conference is returning 2-5 March 2015 at Grand Copthorne Waterfront Hotel, Singapore to prepare you for future growth in the OTC and Consumer Health market in Asia. You will witness how the OTC landscape varies by country as well as the latest product trends, consumer insights and innovative offerings in OTC – a crucial element to achieve global success.
http://www.otcpharmaasia.com
4th Annual OTC Pharma Asia 2014, SingaporeRita Barry
OTC sales in Asia-Pac region (excl. Japan) account for 21% of global OTC sales as of Sept 2012, according to IMS analysis. In fact, for the 3rd consecutive year, Asia-Pac sales have significantly outpaced the global OTC market growth. At the center of the growth, it becomes a priority for Asian consumer health companies to continue reinventing their business as the market becomes more competitive than ever.
The annual OTC conference is the first and only regional platform in Asia to access the latest market trends, regulatory updates, marketing strategies as well as strategic advice by industry experts to achieve sustainable growth and maximize ROI in the evolving consumer health market.
Key Discussion Themes:
Market Entry & Expansion Strategies in Asia
Updates on ASEAN Health Supplement Regulations
Driving OTC Business Growth with Prescription Sales
Promoting OTX/Pharmacist-Only-Medicine
Segment Marketing: Targeting Women, Elderly & Children’s Health
Consumer Trends & Growth Strategies in China & Indonesia’s Consumer Health Market
Launching a New OTC Brand Successfully
OTC Consumer Segmentation, Innovation & Branding Tools
Shopper Marketing for Pharmaceutical Industry
For more information, visit: www.otcpharmaasia.com
The document provides recommendations for MuscleTech to increase its market share in China, including conducting market research, launching in China by the end of 2016, differentiating its brand positioning, building its brand image through ambassadors and campaigns, opening 10 retail stores by 2018, increasing R&D spending to develop products for Chinese consumers, and market testing in Beijing and Shanghai. With these recommendations, MuscleTech expects to achieve 10% market share in Beijing and Shanghai by the end of 2017.
The document discusses the Indian health and wellness market. It notes that the market is worth INR 490 billion and covers segments like beauty and cosmetics, fitness and slimming, nutrition, alternative therapy, and rejuvenation. Younger consumers with higher incomes are driving growth in discretionary spending on wellness. Increased lifestyle diseases and health awareness are also fueling demand for wellness products and services. Medical tourism is seen as a fast-growing segment for India due to lower costs and growing awareness of alternative therapies like Ayurveda. The market is attracting both domestic and international players looking to capitalize on the growth opportunities.
The document discusses the wellness and spa industry in India. It notes that the industry is currently in a growth stage and gaining popularity. Spas have been working to expand their businesses and connect with consumers. There is significant scope for the industry to flourish as lifestyle demands are shifting towards wellness. However, the industry faces limitations like spas unwilling to share customer data and lack of trained professionals. Trends seen include medical tourism and tie-ins between spas and the medical industry. The conclusion is that India presents many opportunities in the growing wellness tourism sector.
This document provides an overview of health and wellness trends in India. It finds that Indians are increasingly health-conscious and spending more on fitness, nutrition, and natural health products. Alternative beverages to carbonated drinks, like reduced-fat flavored milks, are growing in popularity. Fortified foods and beverages are also growing, though consumer awareness remains low. The market for "better-for-you" foods emphasizing reduced fat, sugar, cholesterol, and calories is expanding, especially in urban areas. There were over 1,000 new product launches in India in 2009 focused on these health and wellness attributes. The nutritionals market, including vitamins, herbal products, and slimming aids is also experiencing strong
COMPANY ANALYSIS: PATANJALI
In the present scenario, the market of ‘Wellness Industry’ in India is less than 2% as compared to the international market. There are untapped opportunities in the wellness industry because of which the government has given special focus on this sector in the ‘Make in India’ campaign. Active involvement from private and public players can create huge impact and buzz in the global market. The motives are the expansion and spreading the awareness and usability.
Patanjali Ayurveda is maker of ayurvedic consumer products and is one of the fastest growing consumer companies in India. The company was formed by Baba Ramdev in 1997 in collaboration with Acharya Balkrishna (scholar of Ayurveda, Sanskrit and Vedas) to manufacture ayurvedic medicines. Ramdev has focused on Yoga while Balkrishna is spreading and channelizing Ayurvedic products.
The company provides a bunch of products and services which revolves around the consumer needs. Providing them high-quality products at attractive prices is the USP. It has become a household name. The company sources raw materials directly from farmers to cut middlemen cost for increasing profits.
A successful generic product starts with understanding consumer needs and brand value. On November 4-7 in Singapore, IBC will host the 9th Annual Generics Asia 2014, Asia’s longest running Generics conference, to help you and your organization understand how to incorporate marketing and partnership into your business strategy.
The key topics to be covered at the event include:
Regulatory Update and Accelerating Access to New market
o A panel of experts from Philippines Chamber of Pharmaceutical Industry, Actavis, Hovid and Pfizer
Building Brand Awareness and Delivering New Products with a Cost Effective Strategy
o Allan Marx Ancheta, Director Business Development and Strategy, Commercial Innovation and Alliance, Merck
Managing Sale Force Effectiveness and Innovative Channels for Generics Products
o Marvin Biliwang, Commercial Effectiveness Director, Takeda Pharmaceuticals
Establishing Partnerships to Add Value and Build Market Share
o Philip Cox, President Director, PT Takeda Indonesia
Innovative Models and Super Generics for Prolonging Product Life Cycles
o Dr. Shirish Kulkarni, Senior Vice President, Formulation Development, Sun Pharmaceutical
This document provides a summary of an individual's career experience in pharmaceutical sales and business development over 22 years. It outlines the individual's roles and accomplishments at various pharmaceutical companies, including establishing relationships with physicians, launching new products, developing sales strategies, and leading sales teams to achieve sales targets and growth. The individual's most recent role is as General Manager of Sales and Marketing at Cadila Pharmaceuticals since 2013, where responsibilities include directing distributor management, leading commercial strategy implementation, and reinvigorating the sales team.
PSS Herbs India: Synergy of Ayurveda & Modern Pharma for Global Healthcare/Nu...vinoth_s
An business idea with huge potential seeking investment in seed round.
The products offers $62 Billion global herbal market with high-quality and proven herbal supplements, medications and also bulk actives (APIs) for manufacture of Allopathic, Ayurveda, Siddha and Unani medications.
The advantage of investing in this company rather than any other existing company is its unique business focus. While other existing companies are not having broad look at business potential and are going blindly by old market numbers, I have precisely captured the market potential and need in each of the segments through a thorough market research. This business intelligence gives PSS Herbs India the insight to reach the market on-time with the right offering that market is looking for in the price and quantity that makes the business a success and reputable brand.
Innovative Marketing Practices for Optimization in Selected Pharmaceutical In...iicecollege
Pharmaceutical Industry is regulated by the production, distribution, selling and the marketing of the products or services which directly or indirectly includes medical, diagnostic and healthcare.It is regulated by economical, political and administrative authority to manage at all levels. So, the industry is governed by both the public and private sector. Therefore innovation is done in various pharma stakeholder and is needed in chronic and acute therapeutic segment.
For more details please visit
www.iicecollege.com
This document provides an overview of a Healthy Corner Store Project toolkit created by Sustainable Long Island. The project aims to improve access to healthy foods in underserved communities by partnering with corner store owners. Key aspects of the toolkit include conducting assessments of neighborhood demographics and store inventories, interacting with customers and the community through surveys and outreach, strategically partnering with store owners by providing incentives and support, and monitoring the program's impact through sales tracking and evaluations. The toolkit also outlines successful features of similar programs in other cities that could be replicated, such as increasing healthy product selection and making those products more prominent. If implemented properly using the guidance in this toolkit, the project seeks to create healthier food environments and communities.
This marketing plan document outlines the marketing strategy for Ayush Raksha Aleovera, an Ayurvedic health supplement. It discusses the product details and benefits of Aleovera. The target customer is identified as health conscious individuals, children, senior citizens, and influencers like doctors and nutritionists. The plan proposes establishing distribution through medical shops, Ayurvedic stores, supermarkets, and general stores. It provides details on the sales team structure, their roles and compensation. Online promotion strategies and branding ideas are also suggested. Key actions include pricing strategy, promotion through exhibitions, festivals and colleges.
Patanjali Ayurved Ltd is an Indian FMCG company known for its herbal products. It has grown rapidly in recent years to become the 2nd largest FMCG company in India, overtaking older competitors. Patanjali utilizes marketing strategies such as associating with Baba Ramdev, promoting Indian/Ayurvedic products, keeping prices low, extensive advertising, and focusing on health-conscious customers. Its success is attributed to identifying opportunities, strong distribution channels, promoting national pride, and quality herbal products.
Final Country Entry Business Report- Jose Echevarria (1)Jose Echevarria
This document provides an analysis of entering the Chinese market with a new traditional Chinese medicine product. It includes a mission statement, industry analysis, country analysis, and financial projections. Key points:
1) The author proposes a nutrient patch that delivers traditional Chinese medicines through the skin for convenience. The target market is China's large aging population in cities like Shanghai and Tianjin.
2) The traditional Chinese medicine industry in China is large but highly competitive. The top competitors have technological advantages that an international company could potentially overcome with innovation.
3) Sales projections for the first year estimate capturing 0.1% market share, or sales of 223,438 patches. Success will depend on effective distribution and marketing to gain
Transpharmation Masterclass: Build your Customised Pharmacy Retail CategoryRobert Sztar
The document discusses how to build a customized retail category for pharmacies focusing on continence. It recommends defining the niche customer segment, designing the category around customer wants and needs, and addressing common challenges. Examples are given of defining continence demographics and customer issues as well as merchandising, signage, and services to engage customers and ensure repeat visits. Common challenges mentioned include lack of store space. The overall goal is to differentiate pharmacies by creating a dedicated health category focused on customer care.
The document provides information about a study conducted on customer perception of the Patanjali brand. It discusses the company background and objectives of the study. A literature review and research methodology used are also outlined. The data analysis findings from a survey of 87 customers show that most users find Patanjali products to be of good quality, effective, natural and herbal. The majority were satisfied with the products and felt quality and price were important factors. In conclusion, Patanjali has a favorable brand perception and is giving competition to other FMCG companies in India.
Analysis of Consumer Satisfaction for Patanjali ProductsMansi Sadhu
This presentation is assembled by a survey conducted to analyze the consumer satisfaction level for Patanjali products. These findings are based on the studies and references from various documents.
detailed evaluation of the marketing mix of sun pharmaceutical company, the advantages & disadvantages of the 7 P's with reference to the sun pharma and a strategic evaluation of their marketing strategy compared to Dr. Reddy
Patanjali Ayurveda aims to commercialize business in a non-commercial way. It has built a 2,500 crore business in a decade through Baba Ramdev's interactions, discovering initial consumers among his 70 million followers, and offering products at 20-25% cheaper prices than competitors. Patanjali is exploring the United Arab Emirates market, which has a large Indian population receptive to herbal products. It plans to target children, middle-aged women, and those aged 15-64, and position its herbal and Ayurvedic products as treating diseases with zero side effects. Patanjali will implement value-based pricing and franchise-based distribution in the UAE market. It
Top 10 pharma manufacturers in chandigarhAditiMehra14
Listed pharma manufacturers are the top and best pharma PCD medicine manufacturers in Chandigarh. In our blog of pharmaadda, we provide all the genuine information about pharma and ayurvedic companies for the readers.
List of pharma companies in Mohali | PharmaaddaAditiMehra14
Mentioned above is the List Of Pharma Companies in Mohali. Invest in these pharma franchise companies for growth. For More details visit the blog. http://www.pharmaadda.in/list-of-pharma-companies-in-mohali
In 2011, Glenmark Pharmaceuticals, a leading pharma company in India, launched its cometology division by the name CosmoCare. They introduced IDC range of anti-aging products and IntelliAssist was the creative agency appointed for product launch and ongoing communication.
Here is a short summary of collateral we created for product launch and campaign we managed to create awareness and promote product USP.
This document discusses Patanjali's potential expansion into the Malaysian market. It provides an overview of Patanjali as an Indian FMCG company and Ayurvedic products manufacturer. It then discusses the cultural compatibility between India's Ayurvedic traditions and traditional Malaysian medicine. The document argues that Patanjali could find success in Malaysia due to the popularity of Ayurveda and herbal remedies there as well as the large Indian population. It proposes several marketing strategies for Patanjali to enter the Malaysian market, including free health camps and positioning products at affordable price points.
Patanjali Ayurved is an Indian FMCG company established in 2006 and headquartered in Haridwar, Uttarakhand. It manufactures herbal and Ayurvedic products in categories such as food, personal care, home care, and medicines. The company has grown exponentially in recent years with revenues reaching 50 billion INR in 2015-2016. Its success is attributed to affordable prices, quality natural products, and promotion through Baba Ramdev's yoga teachings and media appearances. Patanjali is projected to continue high growth and become the second largest FMCG company in India by focusing on rural expansion, R&D, and increasing exports.
The document discusses the Association of Southeast Asian Nations (ASEAN). It provides details on:
1) ASEAN was established in 1967 by Indonesia, Malaysia, Philippines, Singapore and Thailand to promote regional stability and economic growth following their independence movements.
2) ASEAN now includes 10 member countries and has established various goals and initiatives to promote integration, including establishing the ASEAN Community by 2015 consisting of the ASEAN Political-Security Community, ASEAN Economic Community, and ASEAN Socio-Cultural Community.
3) Thailand chaired ASEAN in 2014 and focused on fully establishing the ASEAN Community through various frameworks and plans to promote cooperation across member states.
The goal of Pick-Up Sticks is to remove sticks from a pile one at a time without disturbing the other sticks. Players take turns carefully picking up a single stick until all sticks have been removed. If a stick is moved in the process, the player's turn ends. The last player with sticks left wins.
COMPANY ANALYSIS: PATANJALI
In the present scenario, the market of ‘Wellness Industry’ in India is less than 2% as compared to the international market. There are untapped opportunities in the wellness industry because of which the government has given special focus on this sector in the ‘Make in India’ campaign. Active involvement from private and public players can create huge impact and buzz in the global market. The motives are the expansion and spreading the awareness and usability.
Patanjali Ayurveda is maker of ayurvedic consumer products and is one of the fastest growing consumer companies in India. The company was formed by Baba Ramdev in 1997 in collaboration with Acharya Balkrishna (scholar of Ayurveda, Sanskrit and Vedas) to manufacture ayurvedic medicines. Ramdev has focused on Yoga while Balkrishna is spreading and channelizing Ayurvedic products.
The company provides a bunch of products and services which revolves around the consumer needs. Providing them high-quality products at attractive prices is the USP. It has become a household name. The company sources raw materials directly from farmers to cut middlemen cost for increasing profits.
A successful generic product starts with understanding consumer needs and brand value. On November 4-7 in Singapore, IBC will host the 9th Annual Generics Asia 2014, Asia’s longest running Generics conference, to help you and your organization understand how to incorporate marketing and partnership into your business strategy.
The key topics to be covered at the event include:
Regulatory Update and Accelerating Access to New market
o A panel of experts from Philippines Chamber of Pharmaceutical Industry, Actavis, Hovid and Pfizer
Building Brand Awareness and Delivering New Products with a Cost Effective Strategy
o Allan Marx Ancheta, Director Business Development and Strategy, Commercial Innovation and Alliance, Merck
Managing Sale Force Effectiveness and Innovative Channels for Generics Products
o Marvin Biliwang, Commercial Effectiveness Director, Takeda Pharmaceuticals
Establishing Partnerships to Add Value and Build Market Share
o Philip Cox, President Director, PT Takeda Indonesia
Innovative Models and Super Generics for Prolonging Product Life Cycles
o Dr. Shirish Kulkarni, Senior Vice President, Formulation Development, Sun Pharmaceutical
This document provides a summary of an individual's career experience in pharmaceutical sales and business development over 22 years. It outlines the individual's roles and accomplishments at various pharmaceutical companies, including establishing relationships with physicians, launching new products, developing sales strategies, and leading sales teams to achieve sales targets and growth. The individual's most recent role is as General Manager of Sales and Marketing at Cadila Pharmaceuticals since 2013, where responsibilities include directing distributor management, leading commercial strategy implementation, and reinvigorating the sales team.
PSS Herbs India: Synergy of Ayurveda & Modern Pharma for Global Healthcare/Nu...vinoth_s
An business idea with huge potential seeking investment in seed round.
The products offers $62 Billion global herbal market with high-quality and proven herbal supplements, medications and also bulk actives (APIs) for manufacture of Allopathic, Ayurveda, Siddha and Unani medications.
The advantage of investing in this company rather than any other existing company is its unique business focus. While other existing companies are not having broad look at business potential and are going blindly by old market numbers, I have precisely captured the market potential and need in each of the segments through a thorough market research. This business intelligence gives PSS Herbs India the insight to reach the market on-time with the right offering that market is looking for in the price and quantity that makes the business a success and reputable brand.
Innovative Marketing Practices for Optimization in Selected Pharmaceutical In...iicecollege
Pharmaceutical Industry is regulated by the production, distribution, selling and the marketing of the products or services which directly or indirectly includes medical, diagnostic and healthcare.It is regulated by economical, political and administrative authority to manage at all levels. So, the industry is governed by both the public and private sector. Therefore innovation is done in various pharma stakeholder and is needed in chronic and acute therapeutic segment.
For more details please visit
www.iicecollege.com
This document provides an overview of a Healthy Corner Store Project toolkit created by Sustainable Long Island. The project aims to improve access to healthy foods in underserved communities by partnering with corner store owners. Key aspects of the toolkit include conducting assessments of neighborhood demographics and store inventories, interacting with customers and the community through surveys and outreach, strategically partnering with store owners by providing incentives and support, and monitoring the program's impact through sales tracking and evaluations. The toolkit also outlines successful features of similar programs in other cities that could be replicated, such as increasing healthy product selection and making those products more prominent. If implemented properly using the guidance in this toolkit, the project seeks to create healthier food environments and communities.
This marketing plan document outlines the marketing strategy for Ayush Raksha Aleovera, an Ayurvedic health supplement. It discusses the product details and benefits of Aleovera. The target customer is identified as health conscious individuals, children, senior citizens, and influencers like doctors and nutritionists. The plan proposes establishing distribution through medical shops, Ayurvedic stores, supermarkets, and general stores. It provides details on the sales team structure, their roles and compensation. Online promotion strategies and branding ideas are also suggested. Key actions include pricing strategy, promotion through exhibitions, festivals and colleges.
Patanjali Ayurved Ltd is an Indian FMCG company known for its herbal products. It has grown rapidly in recent years to become the 2nd largest FMCG company in India, overtaking older competitors. Patanjali utilizes marketing strategies such as associating with Baba Ramdev, promoting Indian/Ayurvedic products, keeping prices low, extensive advertising, and focusing on health-conscious customers. Its success is attributed to identifying opportunities, strong distribution channels, promoting national pride, and quality herbal products.
Final Country Entry Business Report- Jose Echevarria (1)Jose Echevarria
This document provides an analysis of entering the Chinese market with a new traditional Chinese medicine product. It includes a mission statement, industry analysis, country analysis, and financial projections. Key points:
1) The author proposes a nutrient patch that delivers traditional Chinese medicines through the skin for convenience. The target market is China's large aging population in cities like Shanghai and Tianjin.
2) The traditional Chinese medicine industry in China is large but highly competitive. The top competitors have technological advantages that an international company could potentially overcome with innovation.
3) Sales projections for the first year estimate capturing 0.1% market share, or sales of 223,438 patches. Success will depend on effective distribution and marketing to gain
Transpharmation Masterclass: Build your Customised Pharmacy Retail CategoryRobert Sztar
The document discusses how to build a customized retail category for pharmacies focusing on continence. It recommends defining the niche customer segment, designing the category around customer wants and needs, and addressing common challenges. Examples are given of defining continence demographics and customer issues as well as merchandising, signage, and services to engage customers and ensure repeat visits. Common challenges mentioned include lack of store space. The overall goal is to differentiate pharmacies by creating a dedicated health category focused on customer care.
The document provides information about a study conducted on customer perception of the Patanjali brand. It discusses the company background and objectives of the study. A literature review and research methodology used are also outlined. The data analysis findings from a survey of 87 customers show that most users find Patanjali products to be of good quality, effective, natural and herbal. The majority were satisfied with the products and felt quality and price were important factors. In conclusion, Patanjali has a favorable brand perception and is giving competition to other FMCG companies in India.
Analysis of Consumer Satisfaction for Patanjali ProductsMansi Sadhu
This presentation is assembled by a survey conducted to analyze the consumer satisfaction level for Patanjali products. These findings are based on the studies and references from various documents.
detailed evaluation of the marketing mix of sun pharmaceutical company, the advantages & disadvantages of the 7 P's with reference to the sun pharma and a strategic evaluation of their marketing strategy compared to Dr. Reddy
Patanjali Ayurveda aims to commercialize business in a non-commercial way. It has built a 2,500 crore business in a decade through Baba Ramdev's interactions, discovering initial consumers among his 70 million followers, and offering products at 20-25% cheaper prices than competitors. Patanjali is exploring the United Arab Emirates market, which has a large Indian population receptive to herbal products. It plans to target children, middle-aged women, and those aged 15-64, and position its herbal and Ayurvedic products as treating diseases with zero side effects. Patanjali will implement value-based pricing and franchise-based distribution in the UAE market. It
Top 10 pharma manufacturers in chandigarhAditiMehra14
Listed pharma manufacturers are the top and best pharma PCD medicine manufacturers in Chandigarh. In our blog of pharmaadda, we provide all the genuine information about pharma and ayurvedic companies for the readers.
List of pharma companies in Mohali | PharmaaddaAditiMehra14
Mentioned above is the List Of Pharma Companies in Mohali. Invest in these pharma franchise companies for growth. For More details visit the blog. http://www.pharmaadda.in/list-of-pharma-companies-in-mohali
In 2011, Glenmark Pharmaceuticals, a leading pharma company in India, launched its cometology division by the name CosmoCare. They introduced IDC range of anti-aging products and IntelliAssist was the creative agency appointed for product launch and ongoing communication.
Here is a short summary of collateral we created for product launch and campaign we managed to create awareness and promote product USP.
This document discusses Patanjali's potential expansion into the Malaysian market. It provides an overview of Patanjali as an Indian FMCG company and Ayurvedic products manufacturer. It then discusses the cultural compatibility between India's Ayurvedic traditions and traditional Malaysian medicine. The document argues that Patanjali could find success in Malaysia due to the popularity of Ayurveda and herbal remedies there as well as the large Indian population. It proposes several marketing strategies for Patanjali to enter the Malaysian market, including free health camps and positioning products at affordable price points.
Patanjali Ayurved is an Indian FMCG company established in 2006 and headquartered in Haridwar, Uttarakhand. It manufactures herbal and Ayurvedic products in categories such as food, personal care, home care, and medicines. The company has grown exponentially in recent years with revenues reaching 50 billion INR in 2015-2016. Its success is attributed to affordable prices, quality natural products, and promotion through Baba Ramdev's yoga teachings and media appearances. Patanjali is projected to continue high growth and become the second largest FMCG company in India by focusing on rural expansion, R&D, and increasing exports.
The document discusses the Association of Southeast Asian Nations (ASEAN). It provides details on:
1) ASEAN was established in 1967 by Indonesia, Malaysia, Philippines, Singapore and Thailand to promote regional stability and economic growth following their independence movements.
2) ASEAN now includes 10 member countries and has established various goals and initiatives to promote integration, including establishing the ASEAN Community by 2015 consisting of the ASEAN Political-Security Community, ASEAN Economic Community, and ASEAN Socio-Cultural Community.
3) Thailand chaired ASEAN in 2014 and focused on fully establishing the ASEAN Community through various frameworks and plans to promote cooperation across member states.
The goal of Pick-Up Sticks is to remove sticks from a pile one at a time without disturbing the other sticks. Players take turns carefully picking up a single stick until all sticks have been removed. If a stick is moved in the process, the player's turn ends. The last player with sticks left wins.
The pharmaceutical market in Indonesia is growing rapidly. GDP growth reached 6.1% in 2010 and nominal GDP is projected to grow 15% to around Rp7,500 trillion in 2011. Total health expenditure as a percentage of GDP has averaged 2% but the government aims to increase this to 5% by 2015 through expanding national health insurance. The growing middle class, rising incomes, urbanization, and focus on healthcare are driving demand for pharmaceutical products. The pharmaceutical industry in Indonesia is dominated by domestic firms and relies heavily on imported active pharmaceutical ingredients. The market is expected to continue strong growth of 13.4% annually through 2014 due to economic and demographic factors.
The strategic schedule outlines the priority actions from 2008-2015 to achieve a single market and production base in ASEAN. Key actions include completing tariff reductions on all products to 0-5% for Cambodia, Laos, Myanmar and Vietnam by 2015. It also aims to eliminate non-tariff barriers for ASEAN-5 by 2010, Philippines by 2012, and CLMV by 2015. The schedule focuses on reforming rules of origin and simplifying certification procedures to facilitate free flow of goods across ASEAN.
The document discusses the Indo-Asean Free Trade Agreement (FTA). Some key points:
- The FTA aims to eliminate tariffs between India and ASEAN nations over a period of time through normal and sensitive tracks, with rules of origin requiring a minimum 35% value addition within ASEAN/India.
- It allows for non-tariff measures and safeguards by member countries. Tariff reductions will benefit certain Indian exports and imports from ASEAN nations.
- India's exports to ASEAN grew from $19 billion in 2008-2009 to $18 billion in 2009-2010, while imports increased from $25 billion to $26 billion over the same period. Specific industries may face
The document discusses the ASEAN Community Councils and the three pillars that comprise the ASEAN Community - the ASEAN Political-Security Community, ASEAN Economic Community, and ASEAN Socio-Cultural Community. It provides details on the goals and blueprints for each pillar, which aim to promote political stability, equitable economic development, and enhance social well-being among ASEAN countries. Key areas of focus include establishing a single market, liberalizing trade and investment, protecting human rights, narrowing development gaps, and investing in education and healthcare.
South East Asia Pharmaceutical Markets Jamie Davies October 2014jamiedavies12345
The document discusses trends in the pharmaceutical market in Southeast Asia. It forecasts strong growth in the region but identifies risks like protectionism, intellectual property issues, and pricing and reimbursement challenges. The economy is expected to outperform globally and universal healthcare is becoming more politically important. Companies need region-specific strategies given the diversity across Southeast Asian markets that are undergoing economic and regulatory integration.
Asean a community of opportunities (overview ppt) jan2015Channy Leang
The document provides an overview of ASEAN (Association of Southeast Asian Nations), which consists of 10 member states representing over 600 million people and a combined GDP of $2.4 trillion. It summarizes ASEAN's goals of establishing three communities - political-security, economic, and socio-cultural - by 2015 to promote cooperation and accelerate economic growth. Key achievements include agreements reducing barriers to trade, investment, services, and mobility of skilled labor. Going forward, ASEAN aims to deepen integration through its post-2015 vision of a politically cohesive, economically integrated, and socially responsible community.
An introductory overview of healthcare across South East Asia and a look at the growing healthcare trends across the region.
Download the presentation by clicking the "Save this presentation" icon above.
The Association of Southeast Asian Nations (ASEAN) was established in 1967 by Indonesia, Malaysia, Philippines, Singapore, and Thailand. It has since expanded to include 10 member countries and aims to accelerate economic growth, social progress, and cultural development while maintaining regional peace and stability. ASEAN faces challenges such as financial crises, transboundary haze pollution, and disputes but has taken steps like the ASEAN Surveillance Process and ASEAN+3 Financial Cooperation to prevent future crises and foster cooperation. ASEAN also presents many opportunities for economic growth and development across member countries in the coming years.
ASEAN was established in 1967 by five Southeast Asian countries to promote economic, social, and cultural development in the region. It has since expanded to include 10 member countries and has established dialogue partnerships with 10 other nations. ASEAN aims to safeguard regional stability and serve as a forum for resolving intra-regional issues. Over the years, ASEAN has helped foster peace and prosperity in Southeast Asia through regional cooperation. It is now the fourth largest trading bloc globally and continues working towards greater integration among its member states.
The document provides information about the 8th Asia Generics Conference taking place from 11-14 November 2013 in Singapore. The conference will discuss topics related to developing competitive strategies for pricing, portfolio management, and market access in the generics industry in Asia. It outlines an agenda with sessions on market outlook, regulatory pathways, market access opportunities, product differentiation, branding, distribution, and strategic partnerships. Speakers include representatives from Johnson & Johnson, Pfizer, Unilab, and other pharmaceutical companies. Workshops on go-to-market innovation and biosimilars entry are also advertised.
Medical Device Asia Conference, 28-31 Oct 2014, SingaporeLei Ching Y.
MED DEVICE ASIA is the only high level platform in Asia to showcase innovative ideas, trends in partnerships with public sector and clinicians and to network with experts and industry leaders to find out about regulatory updates, investment opportunities, product development and market access.
This document provides information about the 3rd Annual Medical Affairs Asia Summit taking place from August 26-29, 2014 in Singapore. The summit will feature over 85% new speakers and focus on advancing effective communication and collaboration with internal and external stakeholders. It will include keynote speeches, panel discussions, and workshops on topics like medical affairs strategies, stakeholder engagement, regulatory trends, and collaborating with marketing. The event is aimed at medical affairs professionals in the pharmaceutical and healthcare industries in Asia.
This document provides an agenda for the IBC Life Sciences conference taking place August 26-29, 2014 in Singapore. The conference will feature over 25 R&D expert speakers and focus on licensing, M&A, regulations, investment opportunities, clinical trial development in Asia, intellectual property strategies, and more. Key panelists and speakers include representatives from Pfizer, Sanofi, GSK, and other major pharmaceutical companies. The agenda outlines presentations and panel discussions on topics like Asia's pharmaceutical market outlook, strategic partnerships, clinical trial risks in Southeast Asia, biosimilars and generics R&D, and driving drug innovation in the region.
The inaugural Philippines Healthcare will focus on investment opportunities in the Philippines healthcare sector as well as examine the developments in healthcare plans and policies by government, market access opportunities for pharma and technology, new healthcare facility projects, upgrades and expansions and increasing efficiencies of existing facilities.
Philippines is currently focused on speeding up health facilities and upgrades, meeting the needs and growing demand for health specialists, training to ensure competency and quality of healthcare services and ensuring the availability of drugs throughout the country.
The conference will have discussions on policy and regulation updates, investment opportunities, projects and developments to strengthen Philippines healthcare infrastructure and delivery.
It will be held in Manila and will have representations from government, hospitals, insurance companies, pharma companies, health technology and medical device providers and other related stakeholders.
IPM grew at a CAGR OF 17.5% between 2005 -2016
The maeket Projected to reach 55 billion in sales by 2020 with a CAGR of 16 %
The growth was driven by factors such as increase consumer spending, rapid urbanization etc
Branded products constituted nearly 80% of the Indian pharmaceutical industry in terms of revenues
Equity master report ranked India 3rd in terms of volume and 13th in terms of value to become the 6th largest in terms of absolute value by 2020
Generic pharma company founded by Sanjay Pawar in 2010
Based in Thane, Maharashtra; covering Western and Southern India through a network of 300 distributors
Product line includes Diabetic, Gastropathy, Neuropathy, Obesity and Cardiovascular generic drugs
22 product lines in 7 years – rapid growth
IPM grew at a CAGR OF 17.5% between 2005 -2016
The maeket Projected to reach 55 billion in sales by 2020 with a CAGR of 16 %
The growth was driven by factors such as increase consumer spending, rapid urbanization etc
Branded products constituted nearly 80% of the Indian pharmaceutical industry in terms of revenues
Equity master report ranked India 3rd in terms of volume and 13th in terms of value to become the 6th largest in terms of absolute value by 2020
This document provides information about the IBC Oncology Asia conference happening from November 25-28, 2014 in Singapore. The conference will focus on clinical development and market access strategies for oncology drugs in Asia. It will feature speakers from pharmaceutical companies discussing topics like market trends, developing competitive pipelines, biosimilars, clinical trials, understanding oncologists, market access strategies, pricing and reimbursement. There will also be pre and post-conference workshops on oncology clinical trials, biosimilars, and pricing and reimbursement models. The conference aims to help attendees learn how to expedite oncology drug development and successfully access cancer drug markets in Asia.
The 8th Health Insurance Asia provides a platform to discuss business potential in emerging markets (Indonesia, Vietnam, Philippines & more), updates in regulations, effective marketing, insurance product innovation, claims management & effective partnerships with stakeholders.
Biomanufacturing in China: Technologies and Facility DesignRita Barry
Join us as we DISCOVER, ANALYZE and LEARN the current state of the global biomanufacturing industry and the future growth potential and recent developments in Asia.
Some of the Key Highlights You Won’t Want to Miss Include
USA
Smart & Flexible Manufacturing Solutions in Multi-Product Facilities
Franz Walz, Executive Director Global Manufacturing, Science and Technology & Network Coordination, BOEHRINGER INGELHEIM
EUROPE
MAb Manufacturing Facilities for China & Automated Single-Use Processing to Bring Control & Flexibility to Manufacturing
Pauline Nicholson, Global Product Manager, Allegro Single-Use Systems, PALL
Niels Guldager, Senior Technology Partner, NNE PHRAMAPLAN
KOREA:
How to Bring Global Biopharmaceutical Capability through its Fully-Integrated Production Facilities?
Jeremy Caudill, Global VP Business Development, SAMSUNG BIOLOGICS
SINGAPORE
What do Investors Look for When Investing in Biologics Manufacturing?
Steven Lee, Global Head of Biologics Tech Operations & Managing Director, DR. REDDY'S LABORATORIES
INDIA
Developing a Multiproduct Facility for Biosimilars & Engineering & Biomanufacturing of Enzymes for Different Applications
Arvind Mishra, Global Head of Quality & Regulatory & Head of Strategic Business Unit, Biologicals,
CADILLA PHARMACEUTICALS
Ravindra Wagh, Vice President, ZYDUS BIOLOGICS
Rajeev Soni, Senior Manager, R&D, NOVOZYMES
HONGKONG
What are the Experiences & What is the Future for the Investors in the Biomanufacturing Space?
Ramesh Rajentheran, Head of Asian Healthcare Investment Banking, BARCLAYS
Jason Mann, Managing Director, FENEX CAPITAL MANAGEMENT
INDONESIA
Improving Quality Control & Maintenance of Global Biological Product Distribution
Galatia Chandra, Head of Sales & System, Global Operation, KALBE INTERNATIONAL PTE LTD
http://www.biomanufacturing-asia.com
What’s NEW in 2015’s program?
• More case studies on successful commercialization
• Insights on developing biosimilars under new CFDA guideline
• Emerging business models in regulated and developing markets
• New and timely topics on:
o Valuating biosimilars investments
o Successful technology transfer
o Key criteria in gaining approval
Also, NEW Expert Faculty includes:
Dr Shin Jae Chang, Vice President, Celltrion, Korea
Ira Jacobs, Global Oncology Lead, Biosimilars, Pfizer, US
Paul Thomas, Business Unit Head – Biosimilars, Biocon, India
Dr. Martina A. Sersch, Global Clinical Lead, Oncology Global Development, APAC Biotherapeutics Lead, Genentech, Inc. / F. Hoffmann-La Roche Ltd.
Raj Kannan, Vice President, Commercial Head, Biosimilars, Merck, Switzerland
Huiguo (Forrest) Hu, General Manager of International Business, Shanghai CP Guojian Pharmaceutical Co., Ltd, China
Ko Chung Lin, Chief Executive Officer, PharmaEssentia Corporation, Taiwan
Wen Yong, Vice Director, Drug Research Institutes, Biopharmaceutical Institute, Jiangsu AoSaiKang Pharmaceutical Co Ltd, China
http://www.biosimilarsasia.com
This document provides an agenda for the "Successfully Navigating the Biosimilars Landscape and Shaping Opportunity in 2015 and Beyond" conference taking place from 19-22 May 2015 in Shanghai, China. The conference will cover topics related to the current global biosimilars landscape, emerging business models and investment opportunities, regulatory developments and approvals in China, the US, and Europe, and technological advances in biosimilars development. Speakers will include representatives from pharmaceutical companies, regulatory agencies, and investment firms. The agenda lists keynote panels, roundtable discussions, and presentations covering these topics over the course of the three-day conference.
This document summarizes a webinar on launching products in India. It introduces representatives from Becton Dickinson India and Apollo Hospitals who discuss their perspectives on distribution and working with hospitals. Key challenges of the Indian market include its large size and fragmentation requiring multi-tier distribution networks. Success requires understanding customer needs, having the right KPIs, building relationships with distributors, and commitment to adapting to the local market. The hospital perspective emphasizes landscape research, solving clear problems, considering alternatives, and adapting to the market.
IBC’s Indonesia Healthcare conference brings together healthcare leaders to discuss evolving policies, opportunities for private healthcare investment, partnerships, projects and initiatives.
Key Conference Themes:
Updates on Regulation and the Road Towards Universal Healthcare Coverage
Hospital Management & Cutting Edge Healthcare Delivery Standards
Digital Marketing and Telehealth Solutions
Healthcare Infrastructure Projects, Investments & Development
Generics & Access to Medicine
Public-Private Partnerships & Collaboration
Why You Must Attend This Year’s Event
Understand the proactive steps to take by hospitals, pharmaceutical and insurance companies for the new Universal Healthcare Coverage policy
Discover partnerships and investment opportunities in Indonesia
Hear different case studies from major hospitals, insurance and pharmaceutical companies
Meet and exchange business cards with your peers during the networking sessions
Learn how to deliver safe and quality healthcare from other Asian countries
SMi Group's European BioNetworks SummitDale Butler
This document is a program for the "European BioNetworks Summit" conference on July 7-8, 2014 in London. The summit will bring together representatives from pharmaceutical, biotechnology, academic, and funding organizations to discuss strategic partnerships and collaborations. Over 12 speakers from companies like Novartis, Bristol-Myers Squibb, Bayer, and Johnson & Johnson will provide presentations on topics like developing business strategies, academic partnerships, pricing and reimbursement, and financing options. Attendees can network and learn how to create successful partnerships to increase innovation and research outcomes. A post-conference workshop on July 9th will focus on clinical development pathways.
Medical Travel Conference Agenda in SingaporeLei Ching Y.
Featuring C - level executives from Asia's hospitals, IBC’s Medical Travel 2014 unveils medical tourism market forces and evaluates how leading industry players strategize to meet the growing demand for high quality healthcare. Through interactive and intensive knowledge sharing sessions, this conference creates a single platform for high level networking and learning between leading healthcare providers and key market players in driving patient-centered, affordable and quality healthcare services for global expansion.
International and regional experts coming together
to discuss strategies and opportunities in the Medical
Affairs function
• Unique insights and case studies on experiences in
the Asia market, successful programmes and best
practices
• Detailed and practical workshop to complement
your learning and networking experience
ETOP Analysis of Patanjali this study is for acknowledgement of our Patanjali...Praveer Pandey
This document provides an ETOP (Environmental Threats and Opportunities Profile) analysis of Patanjali, an Indian consumer goods company. The analysis identifies 5 main threats to Patanjali including intense competition, regulatory challenges, supply chain vulnerabilities, changing consumer preferences, and global economic factors. It also outlines 4 key opportunities for Patanjali relating to rising health consciousness, global expansion, digital marketing trends, and government support of herbal products. The document concludes that regular updates to the ETOP analysis will help Patanjali strategically plan and adapt to changes in the dynamic FMCG industry.
Nova Medical Centre is a chain of daycare surgical centres established in 2009 with its first centre in Koromangala, Bangalore. It has since expanded to other cities like Chennai, Delhi, and Mumbai. Each centre partners with 35-40 renowned surgeons. Nova provides over 700 surgical procedures including gynecology, urology, plastic surgery, and more in a minimally invasive and cost effective manner. Patients are typically discharged within a day. The document recommends developing a strong brand identity and effective communication strategy to increase patient enrollment by 30% and establish Nova as a preferred brand over competitors in the healthcare market.
The MaRS EXCITE (Excellence in Clinical Innovation and Technology Evaluation) program helps innovators collaborate with the health system to accelerate the pace of adoption of innovative health technologies in Ontario and global markets.
At the end of the program, innovators will have feedback and data on the effectiveness, competitiveness, and economic value of their medical devices or health technology. With this data, innovators are better equipped to approach payers in multiple markets for reimbursement.
Prioritized by senior executives from the health system, only technologies that have true breakthrough potential are allowed into the program.
For more information visit www.marsdd.com.
Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...my Pandit
Explore the fascinating world of the Gemini Zodiac Sign. Discover the unique personality traits, key dates, and horoscope insights of Gemini individuals. Learn how their sociable, communicative nature and boundless curiosity make them the dynamic explorers of the zodiac. Dive into the duality of the Gemini sign and understand their intellectual and adventurous spirit.
Taurus Zodiac Sign: Unveiling the Traits, Dates, and Horoscope Insights of th...my Pandit
Dive into the steadfast world of the Taurus Zodiac Sign. Discover the grounded, stable, and logical nature of Taurus individuals, and explore their key personality traits, important dates, and horoscope insights. Learn how the determination and patience of the Taurus sign make them the rock-steady achievers and anchors of the zodiac.
Navigating the world of forex trading can be challenging, especially for beginners. To help you make an informed decision, we have comprehensively compared the best forex brokers in India for 2024. This article, reviewed by Top Forex Brokers Review, will cover featured award winners, the best forex brokers, featured offers, the best copy trading platforms, the best forex brokers for beginners, the best MetaTrader brokers, and recently updated reviews. We will focus on FP Markets, Black Bull, EightCap, IC Markets, and Octa.
SATTA MATKA SATTA FAST RESULT KALYAN TOP MATKA RESULT KALYAN SATTA MATKA FAST RESULT MILAN RATAN RAJDHANI MAIN BAZAR MATKA FAST TIPS RESULT MATKA CHART JODI CHART PANEL CHART FREE FIX GAME SATTAMATKA ! MATKA MOBI SATTA 143 spboss.in TOP NO1 RESULT FULL RATE MATKA ONLINE GAME PLAY BY APP SPBOSS
Storytelling is an incredibly valuable tool to share data and information. To get the most impact from stories there are a number of key ingredients. These are based on science and human nature. Using these elements in a story you can deliver information impactfully, ensure action and drive change.
How to Implement a Strategy: Transform Your Strategy with BSC Designer's Comp...Aleksey Savkin
The Strategy Implementation System offers a structured approach to translating stakeholder needs into actionable strategies using high-level and low-level scorecards. It involves stakeholder analysis, strategy decomposition, adoption of strategic frameworks like Balanced Scorecard or OKR, and alignment of goals, initiatives, and KPIs.
Key Components:
- Stakeholder Analysis
- Strategy Decomposition
- Adoption of Business Frameworks
- Goal Setting
- Initiatives and Action Plans
- KPIs and Performance Metrics
- Learning and Adaptation
- Alignment and Cascading of Scorecards
Benefits:
- Systematic strategy formulation and execution.
- Framework flexibility and automation.
- Enhanced alignment and strategic focus across the organization.
Part 2 Deep Dive: Navigating the 2024 Slowdownjeffkluth1
Introduction
The global retail industry has weathered numerous storms, with the financial crisis of 2008 serving as a poignant reminder of the sector's resilience and adaptability. However, as we navigate the complex landscape of 2024, retailers face a unique set of challenges that demand innovative strategies and a fundamental shift in mindset. This white paper contrasts the impact of the 2008 recession on the retail sector with the current headwinds retailers are grappling with, while offering a comprehensive roadmap for success in this new paradigm.
Building Your Employer Brand with Social MediaLuanWise
Presented at The Global HR Summit, 6th June 2024
In this keynote, Luan Wise will provide invaluable insights to elevate your employer brand on social media platforms including LinkedIn, Facebook, Instagram, X (formerly Twitter) and TikTok. You'll learn how compelling content can authentically showcase your company culture, values, and employee experiences to support your talent acquisition and retention objectives. Additionally, you'll understand the power of employee advocacy to amplify reach and engagement – helping to position your organization as an employer of choice in today's competitive talent landscape.
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.AnnySerafinaLove
This letter, written by Kellen Harkins, Course Director at Full Sail University, commends Anny Love's exemplary performance in the Video Sharing Platforms class. It highlights her dedication, willingness to challenge herself, and exceptional skills in production, editing, and marketing across various video platforms like YouTube, TikTok, and Instagram.
Easily Verify Compliance and Security with Binance KYCAny kyc Account
Use our simple KYC verification guide to make sure your Binance account is safe and compliant. Discover the fundamentals, appreciate the significance of KYC, and trade on one of the biggest cryptocurrency exchanges with confidence.
Understanding User Needs and Satisfying ThemAggregage
https://www.productmanagementtoday.com/frs/26903918/understanding-user-needs-and-satisfying-them
We know we want to create products which our customers find to be valuable. Whether we label it as customer-centric or product-led depends on how long we've been doing product management. There are three challenges we face when doing this. The obvious challenge is figuring out what our users need; the non-obvious challenges are in creating a shared understanding of those needs and in sensing if what we're doing is meeting those needs.
In this webinar, we won't focus on the research methods for discovering user-needs. We will focus on synthesis of the needs we discover, communication and alignment tools, and how we operationalize addressing those needs.
Industry expert Scott Sehlhorst will:
• Introduce a taxonomy for user goals with real world examples
• Present the Onion Diagram, a tool for contextualizing task-level goals
• Illustrate how customer journey maps capture activity-level and task-level goals
• Demonstrate the best approach to selection and prioritization of user-goals to address
• Highlight the crucial benchmarks, observable changes, in ensuring fulfillment of customer needs
Top mailing list providers in the USA.pptxJeremyPeirce1
Discover the top mailing list providers in the USA, offering targeted lists, segmentation, and analytics to optimize your marketing campaigns and drive engagement.
Hamster Kombat' Telegram Game Surpasses 100 Million Players—Token Release Sch...
5th OTC Pharma Asia Conference
1. LIFE SCIENCES
Achieving Global Success with Innovative Offerings in
OTC and Consumer Healthcare
WORKSHOPS:
Produced by:
IBC
5TH ANNUAL
TC Pharma Asia
Alvin So
General Manager Asia
Pacific,
Merck Consumer Care,
Philippines
International Marketing Partner:
Peter Osborne
Managing Director, Asia,
Blackmores, Taiwan
www.otcpharmaasia.com
Life
Sciences
2 - 5 March 2015 | Grand Copthorne Waterfront Hotel, Singapore
Session Spotlight Sponsor:
Associate Sponsor:
Media Partners:
What’s NEW in
2015?
70% new speaker faculty
Consumer health market best
practices
OTC market and consumer insights
from:
• Singapore
• Indonesia
• Philippines
• India
• Taiwan
• Thailand
• USA
• Malaysia
Positioning OTC brands
Rx to OTC switches
Market entry and profitable
expansion
Martina Gripp
Head of Marketing CHC,
Boehringer Ingelheim,
Singapore
Weitarsa Hendarto
Vice President of Consumer
Health & Wellness,
PT. Combiphar, Indonesia
Nilesh Wadhwa
Regional Director Business
Development & Strategy,
Takeda Pharmaceutical,
Singapore
Varun Chopra
Category Director –
Healthcare (OTC),
Reckitt Benckiser, India
Ade Gustian Yuwono
Head of OTC,
Novartis, Indonesia
Ding Ming
Global Wellness Category Medical
Director,
GlaxoSmithKline Consumer
Healthcare, USA
PRE-CONFERENCE: 2 MARCH 2015
A: Online Marketing & Retailing
B: Marketing Innovation in Consumer Health and OTC
POST-CONFERENCE: 5 MARCH 2015
C: Managing a Successful Rx to OTC Switch
D: Health Supplement Regulations and Business Opportunities in ASEAN
and China
2. 5TH ANNUAL
TC Pharma Asia CONFERENCE DAY ONE
Tuesday, 3 March 2015
• Considerations when penetrating developing markets:
geographical differences, consumer buying behaviors, trends
in distribution and availability
~ Myanmar: Is the country ready for OTC companies to go in?
~ China: how foreign OTC companies enter into the market
successfully?
~ Thailand: how OTC companies survive the slow down?
~ Indonesia: Impact on OTC market after implementation of
Universal Healthcare Scheme and is it the right time to enter?
~ India: How foreign investors tapped into this highly
competitive and localized market?
Panelist:
Ade Gustian Yuwono, Head of OTC, Novartis, Indonesia
John Goebel, General Manager, Healthcare, BiO-LiFE
Marketing Sdn Bhd, Malaysia
Product Innovation and Development
14:30 ActiPatch-Changing the Paradigm of OTC Chronic Pain
Therapy
• Shortwave therapy
• Chronic pain
• Non-drug treatment
• New treatment paradigm
Dr Deepak Kotak, Executive Vice President, BioElectronics,
USA
15:00 OTC Innovation in India
• Overview of Indian OTC market
• Decision journey of consumers in India
• Product Innovation and other levers to innovate in OTC in India
Rehan Khan, Managing Director, Abbott, India
15:40 Afternoon Networking and Refreshment Break
16:10 Latest Product Trends and Offerings in OTC:
Global Wellness
• What are the new switched molecules, delivery system and
formats, i.e powders, drink mixes and gummies, to take medicine
and cater for consumers on the go
• Gender and age specific formulations for targeted groups and
catering for their needs with new products
• Intellectual property considerations in OTC R&D
• How to introduce newness in existing products
• Case study on a new product offering
Ding Ming, Global Wellness Category Medical Director,
GlaxoSmithKline Consumer Healthcare, USA
RX to OTC Switches
16:50 Regulations on Rx to OTC Switch
• Regulations on different types of switch: RX to OTC and non-prescriptions
to cosmetics switching
• Considerations during an RX to OTC switch
• Complying to packaging, labeling and advertising regulations
for switched products
• What is Rx to OTC switch in India and how Indian companies &
multinationals can bring about change in OTC market
• Role of local & international products in developing the shape
of OTC market in India
• How regulatory & medical affairs can make a difference in the
Choice of products for differentiated OTC Switch
Dr Noppadon (Nhum) Adjimatera, South East Asia (SEA)
Regional Regulatory and Medical Affairs Director, Reckitt
Benckiser, Thailand
Dr Priti Baijal, Head of Regulatory & Medical Affairs,
South Asia, Reckitt Benckiser, India
17:30 Managing the Transition Process in RX to OTC: Effective
Marketing
• Challenges and opportunities from RX-OTC transitioning
• Trends in switching from nonprescription to cosmetics and
marketing and branding strategies in different switch categories
• Growth strategies for switched products and changing consumer
base from B2B to B2C
• Case study: how other pharma companies had successfully
transited from B2B to B2C
Vineet Singhal, Operating Unit Head – India and South East
Asia (OTC Division), Novartis Consumer Health, India
18:10 Chairman’s Summary of the Day &
End of Conference Day One
8:00 Registration and Morning Coffee
9:00 Welcome from IBC Asia & Speed Networking
9:05 Chairman’s Welcome Remarks
Rehan Khan, Managing Director, Abbott, India
OTC Market Outlook
9:10 Asia’s Consumer Insights – Igniting Communication
Excellence
• Evaluating global OTC growth opportunities and South East Asia
markets: Indonesia, Philippines, China, Myanmar and Vietnam
• Impact of increasing trend of self-medication and online medical
portals on the OTC market
• How will this trend impact Asia OTC marketing strategies?
Martina Gripp, Head of Marketing CHC, Boehringer
Ingelheim, Singapore
9:50 Global Trends and Developments in the Asia-Pacific OTC
Market
• Evaluating global OTC growth opportunities and South East
Asian markets: Indonesia, Philippines, China, Myanmar and
Vietnam
• Impact of increasing trend of self-medication and online doctors
and how do they impact on Asia OTC marketers?
• Analyzing OTC sales data and reengineering business models
to capitalize the trends across different categories:
~ Analgesic and pain relief
~ Allergy, cold and flu remedies
~ Gastrointestinal and Anti-diarrheal
~ Dermatologic
10.30 Morning Networking & Refreshment Break
Market Entry, Competitive Analysis &
Consumer Trends
11:00 Assessing Market Strategies in Entering New and
Developing Markets
• Evaluating the attractiveness of Asian markets
• Overcoming regulatory hurdles for market entry
• Lessons from successful market entry strategies
• Exploring growth opportunities after entering the market
Michael Hofer, Regional Market Expansion Services (MES)
Manager, Business Unit Healthcare, DKSH, Thailand
11:40 Capturing Business Opportunities, M&A’s and
Partnerships in Consumer Healthcare and OTC
• Understanding consumers and demographic changes and
developing new product lines
• Why pharma companies should play the lead in investing in
OTC?
• Changing the approach and mindset by learning from FMCG in
accessing and communicating with consumers
• Recent M&A and partnership activities (joint venture, value chain
partnerships) and how it impacts on the OTC landscape in Asia
• Challenges that private equity players and strategic executives
face to achieve successful M&A deals in the OTC/consumer health
space
• Future direction of M&A in the OTC/consumer health space in
Asia
• Case studies and key learning
Nilesh Wadhwa, Regional Director Business Development &
Strategy, Takeda Pharmaceutical (Asia Pacific), Singapore
12:30 Networking Lunch
13:40 Market Access and Expansion into Established and
Emerging OTC Markets
• Market access entry strategy: import, manufacturing, sales and
distribution
• Assessing product demand and consumer behaviour
• How OTC companies adapt and localize products by using
traditional ingredients
DISCUSSION
PANEL
REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.otcpharmaasia.com
3. 5TH ANNUAL
TC Pharma Asia CONFERENCE DAY TWO
Wednesday, 4 March 2015
8:30 Morning Networking & Coffee
9:00 Chairman’s Opening Remarks
Dr Noppadon (Nhum) Adjimatera, South East Asia (SEA)
Regional Regulatory and Medical Affairs Director, Reckitt
Benckiser, Thailand
Regulatory Update & ASEAN
Harmonization
9:10 South East Asia Health Supplement Regulatory Update
• Current regulatory status in Indonesia, Philippines, Vietnam
• Revision of dietary supplement industry in China and what is
expected to change
• Notification type system
• Registration process and duration
• How would the revised scheme promote investment in China’s
health supplement markets and what’s in it for domestic and
foreign players?
Reg Wuisan, Executive Director, PT. Asia Pacific Consultants,
Past Vice Chair of ASEAN Alliance of Health Supplements
Associations, Indonesia
9:50 ASEAN Harmonization’s Impact on the OTC Market in
2015 and Beyond
• What are the regulatory initiatives in other markets that can be
implemented in the domestic markets and drive OTC growth?
• What are the categories not classified as OTC in other countries?
• How AEC (ASEAN Economic Community) implementation
promotes economic opportunities and how OTC companies
take advantage of the opportunity
• How OTC companies prepare for the changes and business
approach in product development, registration, production and
marketing strategy
Panelists:
Alvin So, General Manager Asia Pacific, Merck Consumer
Care, Philippines
Reg Wuisan, Executive Director, PT. Asia Pacific Consultants,
Past Vice Chair of ASEAN Alliance of Health Supplements
Associations, Indonesia
10:40 Morning Networking & Refreshment Break
Building OTC Brands
11:10 Brand Activation Strategies and Building up a Brand
Image
• Factors and new trends affecting branding decision
• How to launch a new brand in a new market and effective
communication of product benefits to consumers
• Reinforcing brand message in view of competing alternative
products: cheaper generics and rise of natural remedies in the
market
Weitarsa Hendarto, Vice President of Consumer Health &
Wellness, PT. Combiphar, Indonesia
11:50 Challenges in Accessing New Markets in Asia and Building
a Successful VMS Brand
• What are the key drivers in vitamins and dietary supplements
in Asia?
• Which type of supplements are becoming more popular and
where are the opportunities?
• Barriers in venturing into new markets and how to brand build
your VMS product successfully
• Case study on setting up concept stores and connecting with
consumers at point of sales
Peter Osborne, Managing Director, Asia, Blackmores, Taiwan
12:30 Networking Lunch
13:40 Product Differentiation Strategies and Building Brand
Equity
• Key attributes of a successful brand
• Ways to add value to your existing brands and building up brand
image and consumer base for new products
• Innovative ways to differentiate your products with the same
composition and efficacy
• Branding strategies for different OTC product categories and
learning from the successful brands
Panelists:
Weitarsa Hendarto, Vice President of Consumer Health &
Wellness, PT. Combiphar, Indonesia
Brijesh Kapil, General Manager, Merck Consumer Health,
India
PANEL DISCUSSION
OTC Marketing and Distribution
Strategy
14:30 Making a Connection in the Retail Space
• Standing out amongst competitive products and engaging
consumers with products on the shelves
• Going beyond traditional visibility of OTC and consumer
healthcare products
• Overcoming shopper barriers online and offline
• Case study on how FMCG companies connect with consumers
at point of sales successfully
Alvin So, General Manager Asia Pacific, Merck Consumer
Care, Philippines
15:10 Afternoon Networking & Refreshment Break
15:40 Building Distribution Networks to Capitalize on
Expanded Point of Sale Opportunities
• Evaluating geographical differences and trends in distribution
and availability
• Distribution channels from super markets to smaller
neighborhood stores
• New distribution channels to secure greater access and
awareness: health food store, gyms and innovative co-promotion
deals
• Ensuring consistent communication in store across all retailers
and constant stability in stock levels and on shelves
Mahpudz Effendi, National Channel Manager,
GlaxoSmithKline, Indonesia
16:20 Learning from FMCG and their Approach in OTC Branding
and Marketing
• What is the FMCG approach and how can we apply it to OTC
products to improve effectiveness
• Analyzing consumer trends and adapting marketing strategy
according to their needs
• Improving brand loyalty, awareness through effective marketing
and commercial strategy
• How pharma companies can learn from FMCG companies who
penetrated the market successfully
• Case study of successful FMCG approach and profit maximization
Varun Chopra, Category Director – Healthcare (OTC), Reckitt
Benckiser, India
17:00 Chairman’s Summary of the Day & End of Conference
PANEL DISCUSSION
Review from 2014 Participants:
“Had some good insights, and also confirmed some of my thoughts for the OTC business. Definitely a frog in a well which
has jumped out of the well.” ~ Tan Wyeman, Managing Director, Eisai
“It was a good experience. A good platform to learn and share new ideas. The real market examples are unique and can’t
be found in other conferences.” ~ Saftid Ullah Ghumman, Director International Marketing and Sales, CCL Pharmaceuticals
“Excellent and good learning!” ~ Jagannathan Pandalam Kandasamy, Assistant Manager - R&D, Pharmaniaga
“Good insight regarding OTC business in general and ASEAN region in particular.” ~ Kashif Sheikh, Managing Director and
CEO, CCL Pharmaceuticals
REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.otcpharmaasia.com
4. 5TH ANNUAL
TC Pharma Asia WORKSHOPS
PRE-CONFERENCE WORKSHOP | 2 MARCH 2015 | MONDAY
WORKSHOP A
9.00am - 12.30pm
Online Marketing & Retailing
Led by: Susan Josi, Managing Partner, Sorento Healthcare, India
What was once seen as an add on for regular marketing initiatives for a brand,
online marketing has indeed become main stream for most consumer brands today.
It is no different for Consumer Healthcare brands, as consumers are much more
online today than ever before. It’s also interesting to note that while the younger
generation is dominating this medium, even the older age profile consumers are
actively using social media channels and are growing in numbers especially when
researching their health concerns.
This workshop will highlight the trends in online marketing and retailing of healthcare
brands and how marketers should take advantage of this growing opportunity,
touching upon the various nuances, challenges and drivers of this marketing
channel.
• Trending the growing opportunity in online marketing for consumer healthcare
brands (drivers, challenges and regulatory issues)
• Key learning from consumer healthcare brands that have effectively used the
online medium for brand engagement (case studies highlighting success and
failures)
• Online retailing (e-commerce) – how has it worked for consumer healthcare
brands and its future trends
About the Workshop Leader:
Susan is the founder member of Sorento Healthcare, one of India’s leading health & wellness consulting and communications company. She has more than 30 years of experience
in the health & wellness domain. She was earlier the Executive Director of Ogilvy Healthcare (a division of Ogilvy and Mather). A double postgraduate in Pharmacy (UDCT) and
Management, she has also won the best woman entrepreneur award from the Maharashtra Chamber of Commerce in India. She was also a UNIDO scholar from India at the University
of Ghent – Belgium. With her special interests in OTC healthcare and social marketing initiatives, she has facilitated many in-house OTC workshops and conferences in India and
globally.
WORKSHOP B
1.30Pm - 5.00pm
Marketing Innovation in Consumer Health and OTC
Led by: Rodney Hannington, Director Strategy & Innovation, Sprim Asia, Singapore
With increasing competition, it is critical and vital for OTC and consumer health
players to equip themselves with marketing innovation to provide brand
differentiation and tactical marketing strategies in product launch, packaging,
distribution and retailing. In this workshop we will look at the types of commercial
innovation with a focus on the types and role of product claims.
• Review of the types of commercial innovation
• Innovation in fully integrated marketing solutions from marketing strategy,
campaign implementation to track and measure
• Case studies from OTC & Consumer Health
About the Workshop Leader:
Rodney has over 25 years of experience and a deep understanding of Consumer Healthcare in Australia, Asia, Middle East / Africa, Russia and Ukraine. Working and consulting with
SPRIM, Kraft Foods (Mondalez) and Novartis he has broad and extensive in market experience including living in both China and Singapore. Graduating with a Bachelor of Business
Marketing from Monash University, Melbourne Australia, he has focused his career on Healthcare Marketing and Business Strategy & Innovation in Asia Pacific.
POST-CONFERENCE WORKSHOP | 5 MARCH 2015 | THURSDAY
WORKSHOP C
9.00am - 12.30pm
Managing a Successful Rx to OTC Switch
Led by: Jyoti Shiralee, Managing Consultant, Chrysalis Consulting, India
Transitioning from the Rx to the OTX or OTC route is a challenge which often
confronts and perplexes the pharma industry. While the Consumer Product
companies have had an inherent advantage in dominating the OTC space, this
workshop will discuss in a structured way how pharma companies can overcome
their traditional mindsets to leverage the opportunity in the OTC space.
• Leveraging the ethical heritage for enhancing/extending product life cycles
About the Workshop Leader:
• Evolving a new Consumer Centric Business Model for pharma companies
• Role of Branding in Rx- OTC transition - Brand Building /Identity and Architecture
• Leveraging the Power of conventional and alternate media - activation, digital,
social media and e-commerce
• Re-envisaging the Distribution Model to maximize consumer outreach
Jyoti is a marketing professional and organisational leader with over 15 years’ experience in senior leadership roles in Strategic Marketing, Brand Building, Commercial Operations
and Business Consulting with both pharma and consumer product companies - Abbott Nutrition, Dumex - Wockhardt / Zydus Wellness/ Dabur India. She has a strong history of
turning around fledgling brands to positions of market dominance and leadership through successful strategic interventions. Jyoti pioneered the creation of nonexistent / nascent
categories that have changed lifestyles and habits - by repositioning brands redefining competition and creating new consumption opportunities
Led by: Pushpanathan Sundram, Managing Director, Celia Zheng, Policy and Government Affairs Adviser, Wai Mun Poon, Regional Regulatory Affairs Manager,
Yi Fan Jiang, Regulatory Affairs Advisor, EAS Strategic Advice, Singapore
China is in the process of revising the national food safety law with proposed
changes on health supplement regulations. ASEAN is to establish the single market
in 2015 with changes of rules and regulations to facilitate product movement in
the region. This workshop aims to guide participants in navigating the changing
health supplements regulations in China and ASEAN markets. The workshop will
also give participants an overview on the business opportunities brought about
Pushpanathan Sundram is the Managing Director of EAS Strategic Advice and previously
the Deputy Secretary-General of the Association of Southeast Asian Nations (ASEAN) for
the ASEAN Economic Community. Nathan brings over 22 years experience in economics,
trade, policy, regulatory affairs, and government relations. He holds a Master’s degree in
Public Policy from the Lee Kuan Yew School of Public Policy, National University of
Singapore in collaboration with the Kennedy School of Government, Harvard University.
Nathan received the Lee Kuan Yew School Outstanding Alumni Award in 2011 and the
Sahakmetrey Commander’s Medal from Cambodia in 2012 for his contributions to ASEAN
and East Asia.
Celia Zheng is Policy and Government Affairs Adviser at EAS Strategic Advice. She works
primarily on ASEAN and China engagement activities, and ASEAN-China regional policy
and trade-related programmes. She is the coordinator of the secretariat of China-ASEAN
Business Association, where she manages political engagement, monitors trends and
issues in ASEAN-China economic relations and business and handles public relations. She
holds a Bachelor degree in Applied Science majoring in Food Science and Technology
from the National University of Singapore.
Jiang Yi Fan is Regulatory Affairs Adviser at EAS Strategic Advice in Singapore. Coming
from China, Yi Fan brings to the team valuable regulatory experience and technical
knowledge that help clients going into the market of China. She holds a degree in Applied
Science (Honours) majoring in Food Science and Technology from the National University
of Singapore.
Poon Wai Mun is the Regional Regulatory Affairs Manager, EAS Strategic Advice in
Singapore, specializing in regulatory affairs for health supplements in a regional capacity.
Over the last 10 years Wai Mun has actively worked on product registration ranging from
pharmaceuticals to nutritional supplements, as well as regulatory strategy planning for
product development. Wai Mun manages the Secretariat of the ASEAN Technical Scientific
Committee for Traditional Medicine and Health Supplements. She is a biotechnologist
and graduated with a M.Sc. in biopharmaceuticals from the University of New South Wales.
WORKSHOP D
1.30Pm - 5.00pm
Health Food & Supplement Regulations and Business
Opportunities: ASEAN and China
About the Workshop Leaders:
by the ASEAN Economic Community and the ASEAN-China Free Trade Area.
• Business opportunity in ASEAN and China - Free Trade Agreement, Maritime
connectivity and the ASEAN Economic Community 2015
• Overview of Health Food regulations in China and the expected changes
• Overview of the ASEAN health supplements regulations and the harmonized
technical requirements.
REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.otcpharmaasia.com
5. IBC
LIFE SCIENCES
5TH ANNUAL
TC Pharma Asia
2 - 5 March 2015 | Grand Copthorne Waterfront Hotel, Singapore
With uprising trends in self-diagnosis and self-medication, Asia's OTC market is expecting a huge
jump in growth rate as significant share of OTC and VMS markets have yet to be fully explored in
many countries like Indonesia, Vietnam and Myanmar.
IBC’s OTC Pharma Asia is the ONLY regional OTC and health supplement marketing conference in
Asia and a LEADING and exclusive platform featuring success stories from Heads of OTC, health
supplements and consumer health marketers from across the region.
Gain market insights and consumer trends in global and regional consumer healthcare
Understand and prepare for regulatory changes in OTC, VMS and Traditional Medicine
Learn best practices in marketing and branding strategies from leading players
Get the latest updates on product and marketing innovation
Learn to adapt business and marketing approaches to suit market needs in established and
emerging markets
BY GEOGRAPHY
■ Singapore/Malaysia 55%
■ Rest of Southeast Asia (Indonesia,
Who Should Attend?
BY INDUSTRY
■ Pharma Companies: 55%
■ Health Supplement Companies
20%
■ FMCG 10%
■ Distributors 10%
■ Others (Consultants, Packaging
and Labeling and software
providers) 5%
PAST ATTENDING COMPANIES INCLUDE:
A Menarini Asia-Pacific Holdings Pte Ltd • A8 Group, Bayer (South East Asia) Pte Ltd • Bayer Consumer Care AG • Blackmores
(Malaysia) Sdn Bhd • Blackmores (Singapore) Pte Ltd • Boehringer Ingelheim Singapore Pte Ltd • BP Healthcare Group • CB
Fleet International Singapore Pte Ltd • CCL Pharmaceuticals Pvt Ltd • CCM International (Philippines) Inc • CCM Pharmaceuticals
(S) Pte Ltd • CCM Pharmaceuticals Sdn Bhd • CD Pharma India Pvt Ltd • Cipla Ltd • DKSH • DSM Nutritional Products Asia Pacific
Pte Ltd • Eisai (HK) Co Ltd • Galderma (S) Pte Ltd • Glaxosmithkline Consumer Healthcare Ltd • GlaxoSmithKline Philippines
Inc • IMS Health • Indegene Lifesystems Pvt Ltd • Ingelheim (Malaysia) Sdn Bhd • iNova Pharmaceuticals (Australia) • InQpharm
Group • Inqpharm Sdn Bhd/Inqpharm Group • Ipsen Pharma Vietnam • Kalbe International • Legacy Healthcare • Live-Well
Nutraceuticals Sdn Bhd • Lovy Pharmacy Sdn Bhd • Mash Health • Mega Lifesciences Ltd • Merck Pte Ltd • Merz Asia Pacific
Pte Ltd • MSD Pharma (Singapore) Pte Ltd • Mundipharma Pharmaceuticals Sdn Bhd • Mundipharma Pte Ltd • Natural
Health Laboratories Ltd • Nicholas Hall Asia Pacific Pte Ltd • Novartis Asia Pacific Pharmaceuticals Pte Ltd • NTUC Unity
Healthcare Co-operative Limited • OLIC Thailand Ltd • Pascual Consumer Healthcare Corporation • Pfizer Inc • Pharmaniaga
Marketing Sdn Bhd • Pharmaniaga Research Centre Sdn Bhd • Piramal Healthcare Ltd • Prestige Brands International •
Procter & Gamble • Professional Insights Marketing Services • PT Actavis Indonesia • PT Anugerah Pharmindo Lestari •
PT Bintang Toedjoe Indonesia • PT Combiphar • PT Johnson & Johnson Medical • PT Kalbe Farma Tbk • Pt Merck Tbk •
PT Takeda Indonesia • Reckitt Benckiser • Rohto Pharmaceutical Co Ltd • Sanofi-Aventis (Malaysia) Sdn Bhd • Sanofi-
Aventis Singapore Pte Ltd • Santen Pharmaceutical Co Ltd • Takeda Pharmaceuticals (Asia Pacific) Pte Ltd • Teva
Pharmaceutical Investments Singapore Pte Ltd • The People At Work Pte Ltd • United Laboratories - Pediatrica OT •
United Laboratories Inc • Warburg Pincus Asia L L C • YSP Industries Malaysia Sdn Bhd • Zuellig Pharma Asia Pacific
Ltd • And many more...
Thailand, Philippines, Vietnam and
Myanmar) 20%
■ North Asia 10%
■ India 5%
■ USA & Europe 5%
■ Australia & New Zealand 5%
WHY YOU SHOULD SPONSOR?
Position your company as a market leader at this event and our customized Sponsorship & Exhibition package offers
prime exposure to key decision-makers and exceptional branding. To explore the range of thought leadership, speaking,
branding and marketing opportunities available, please contact Ms. Yvonne Leong at Tel: + 65 6508 2489 or
Email: yvonne.leong@ibcasia.com.sg
REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.otcpharmaasia.com
6. REGISTER 3 DELEGATES AND THE
4TH ATTENDS FOR FREE!
Early Bird Rate
Register & pay on or
before 19 Dec 2014
Special Rate
Register & pay on or
before 23 Jan 2015
Group Rate
(3 or more delegates)
Normal Rate
Register & pay after
23 Jan 2015
All Workshops SGD 3,895 SGD 4,095 SGD 4,295 SGD 3,795
3 Workshops ❑ A ❑ B ❑ C ❑ D SGD 3,695 SGD 3,895 SGD 4,095 SGD 3,595
2 Workshops ❑ A ❑ B ❑ C ❑ D SGD 3,395 SGD 3,595 SGD 3,795 SGD 3,295
1 Workshop ❑ A ❑ B ❑ C ❑ D SGD 3,095 SGD 3,295 SGD 3,495 SGD 2,995
SGD 2,695 SGD 2,895 SGD 3,095 SGD 2,595
FEE PER DELEGATE
❑ 4 Day Package: 2 Day Conference +
❑ 3.5 Day Package: 2 Day Conference +
❑ 3 Day Package: 2 Day Conference +
❑ 2.5 Day Package: 2 Day Conference +
❑ 2 Day Conference only
GROUP BONUS – Register 3 Delegates from the same company and the 4th Delegate attends FREE!
• Multiple Bookings Discount pricing is applicable to groups of 3 or more delegates from the same organisation registering for the same event, at the same time.
Fee stated is the discounted price PER DELEGATE. Only one discount applies; either the early bird rate OR special rate OR group rate.
• All fees stated include luncheons, refreshments and complete set of documentation. It does not include the cost of accommodation and travel.
• Registration fees are subject to the prevailing government tax.
FREE
MAIL the attached registration
form with your cheque to
IBC Asia (S) Pte Ltd
c/o Informa Regional Business
Services
111 Somerset Road,
TripleOne Somerset #10-06,
Singapore 238164
Delegate 1 Details Delegate 2 Details
Name: Dr/Mr/Ms
Job Title:
Department
Tel:
Mobile No.:
Email:
Name: Dr/Mr/Ms
Job Title:
Department
Tel:
Mobile No.:
Email:
Delegate 3 Details Delegate 4 Details
GROUP
DISCOUNT
This label contains your priority booking code. To expedite registration, please do not remove label. If you have
already received a copy of this brochure, we apologise. For reasons of confidentiality, your full particulars were not
available to IBC Asia (S) Pte Ltd for deduplication prior to mail drop.
If undelivered, please return to:
111 Somerset Road,
TripleOne Somerset #10-06, Singapore 238164
Tel: +65 6508 2400 Fax: +65 6508 2408
5TH ANNUAL OTC PHARMA ASIA
Email
register@ibcasia.com.sg
Fax
+65 6508 2407
Scan the QR Code with your
smartphone and register today
Customer Service Hotline
+65 6508 2401
Web
www.otcpharmaasia.com
HOTEL INFORMATION
PAYMENT TERMS
CANCELLATIONS / SUBSTITUTION
Should you be unable to attend, a substitute delegate is
welcome at no extra charge. Cancellations must be received in
writing at least 10 business days before the start of the event,
to receive a refund less 10% processing fee per registration.
The company regrets that no refund will be made available for
cancellation notifications received less than 10 business days
before the event.
IMPORTANT NOTE
Please quote the name of the delegate, event title and invoice
number on the advice when remitting payment. Bank charges
are to be deducted from participating organisations own accounts.
Please fax your payment details (copy of remittance advice,
cheque or draft to +65 6508 2407).
Attendance will only be permitted upon receipt of full payment.
Participants wishing to register at the door are responsible to
ensure all details are as published. IBC assumes no further
liability or obligation, beyond the refund of the paid registration
fee, in the event of postponement or cancellation by IBC.
DATA PROTECTION
REG NO. 200108203N
Payment must be received 10 business days prior to the event.
To take advantage of discounts with an expiry date, registration
and payment must be received by the cut-off date.
• Payment by bankers draft or cheque in S$ or US$ should be
made in favour of “IBC Asia (S) Pte Ltd” and mailed to:
IBC Asia (S) Pte Ltd
c/o Informa Regional Business Services
111 Somerset Road, TripleOne Somerset #10-06
Singapore 238164
Attn: The Accounts Receivable Team
• Payment by bank transfer in S$ or US$ made payable to:
IBC Asia (S) Pte Ltd
A/C No.:147-059513-001 (S$)
A/C No.:260-457866-178 (US$)
The Hongkong and Shanghai Banking Corporation Limited
21 Collyer Quay, HSBC Building
Singapore 049320
Bank Swift Code: HSBCSGSG
Bank Code: 7232
• Payment by Credit Card (AMEX, VISA or MasterCard).
The best way to pay by credit card is through our secure
portal built into the website. To pay by phone please indicate
the contact name and details below and our Customer
Services Team will call within 24 hours to take payment.
Please do not send credit card information by email.
The personal information entered during your registration/order,
or provided by you, will be held on a database and may be
shared with companies in the Informa Group in the UK and
internationally. Occasionally, your details may be obtained from
or shared with external companies who wish to communicate
with you offers related to your business activities. If you do not
wish your details to be used for this purpose, please contact our
Database Department at Email: database@ibcasia.com.sg,
Tel: +65 6508 2400 or Fax: +65 6508 2408.
6 EASY WAYS TO REGISTER
RESERVE YOUR PLACE TODAY!
■ Yes! I/We will attend the 5th Annual OTC Pharma Asia
2 – 5 March 2015, Grand Copthorne Waterfront Hotel, Singapore
■ I would like to purchase the conference presentations at SGD1000 + GST (SGD1070) per log in.
Name: Dr/Mr/Ms
Job Title:
Department
Tel:
Mobile No.:
Email:
Who is Head of your Department?
Who is Head of Training?
Company Information
Company Name:
Address:
Main Business/Activity:
Postal Code:
Please photocopy for additional delegates
Name: Dr/Mr/Ms
Job Title:
Department
Tel:
Mobile No.:
Email:
■ I enclose my bankers draft / cheque payable to IBC Asia (S) Pte Ltd
■ I am paying by bank transfer (copy attached)
■ Payment by Credit Card. (AMEX, VISA or MasterCard accepted)
PAYMENT METHOD
(Please tick)
CREDIT CARD PAYMENTS
The best way to pay by credit card is through our secure on-line registration process, simply log on to the website at
www.otcpharmaasia.com and click “Register On-line”. If you would prefer to pay over the phone please complete the contact name
and details and our Customer Services Team will call within 24 hours to take payment. As we treat your credit card information in the
strictest confidence, please do not send payment details by email.
Credit card contact: Department:
Direct phone number: Email:
P46260
Grand Copthorne Waterfront Hotel
392 Havelock Road, Singapore 169663
Contact Person: Tan Ai Li, Asst Director of Events
Mobile: + 65 9006 2432
Tel: +65 6233 1301 | Fax: +65 6233 1177
REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.otcpharmaasia.com